Altogether, our findings in this trial are highly significant because these observed human tumour vessel aberrations directly affect blood flow and thus may significantly impact drug delivery.
← all excerpts
Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy.
1
—
—